| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_067a3c5fff599aa564fefd4d03be8fde |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-316
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7246
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7275
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7278
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-349
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-04012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0452
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0456
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-04525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-352 |
| filingDate |
2015-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adea1c257542dee426770600101697b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_436470ac8ffda440fe0e5334a308ce80 |
| publicationDate |
2018-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10022060-B2 |
| titleOfInvention |
High throughput arrhythmia risk assessment using multilead residua signals |
| abstract |
A method and system for high-throughput prediction of the onset of heart arrhythmias observes trends in abnormal or pathologic morphology of the electrocardiogram (ECG). A first set of ECG signals is monitored from a patient. A baseline measurement is generated from the monitored first set of ECG signals to contain nonpathologic ECG morphologies in each lead. A second set of ECG signals is monitored from the patient and a second baseline measurement is generated from the second set of ECG signals. A residuum signal is generated for each lead based on the baseline measurement and the second baseline measurement. The residuum signals are averaged across the leads. R-wave heterogeneity, T-wave heterogeneity, P-wave heterogeneity, or ST-segment heterogeneity or other indicators of arrhythmia risk or myocardial ischemia are quantified based on the generated residuum signals and the averaged residuum signal. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021059551-A1 |
| priorityDate |
2012-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |